menu search

HRGN / Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results

Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results
HOLLISTON, Mass. , Aug. 9, 2023 /PRNewswire/ -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) ("HRGN" or the "Company"), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trauma and birth defects in the esophagus and other organs, today announced that it will release Q2 2023 financial results on August 14, 2023 and host a conference call and webcast on August 14, 2023 at 9:00 AM ET to discuss financial results and business updates for the second-quarter 2023. Read More
Posted: Aug 9 2023, 14:54
Author Name: PRNewsWire
Views: 112313

HRGN News  

Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results

By PRNewsWire
August 9, 2023

Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results

HOLLISTON, Mass. , Aug. 9, 2023 /PRNewswire/ -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) ("HRGN" or the "Company"), a clinical-s more_horizontal


Search within

Pages Search Results: